1
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Activin B in patients with granulosa cell tumors: serum levels in comparison to inhibin

, , &
Pages 570-574 | Published online: 07 Aug 2009

References

  • Hoskins WJ, Rubin C. Malignant gonadal stromal tumors of ovary: clinical features and Management. In: Coppleson M (ed) Gynologic Oncology. Fundamental Principals and Clinical Practice, Vol. 2. Churchill Livingstone, Edinburgh, 1992: 961–970.
  • Gerhenson D. Management of early ovarian cancer: germ cell and sex-cord stromal tumors. Gynecol Oncol 1994; 55: 262–72.
  • Hines J, Mahmoud A, Moore JL, Fine KP, Lage JM, Barnes WA. Recurrent granulosa-cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 1996; 60: 484–8.
  • Lappöhn RE, Burger H, Bouma J, Bangah M, Krans M, de Bruijn HW. Inhibin as a marker for granulosa cell tumors. New Engl J Med 1989; 321: 790–3.
  • Vihko KK, Bläuer M, Kujansuu E, Vilska S, Albäck T, Tuimala R et al. Activin B. detection by an immuno- radiometric assay in human serum during ovarian stimulation and late pregnancy. Hum Reprod 1998; 13: 841–6.
  • Burger HG. Clinical utility of inhibin measurements. J Clin Endocrinol Metab 1993; 76: 1391–5.
  • Healy DL, Mamers P, Bangah M, Burger HG. Clinical and pathophysiological aspects of inhibin. Hum Reprod; xx (Suppl. 8): 138–40.
  • Slujimer AV, Heineman MJ, Evers JH, de Jong FH. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumor. Acta Endocrinol 1993; 129: 311–4.
  • Jobling T, Burger HG, Mamers P, MacLachlan V, Burger HG, Quinn M et al. A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol, 1994; 55: 285–9.
  • Cooke I, O’Brien M, Charnock FM, Groome N, Ganesan TS. Inhibin as a marker for ovarian cancer. Br J Cancer 1995; 71: 1046–50.
  • Fuller PJ, Chu S, Jobling T, Mamers P, Healy DL, Burger HG. Inhibin subunit gene expression in ovarian canver. Gynecol Oncol 1999; 73: 273–9.
  • Robertson DM, Cahir N, Burger HG, Mamers P, Groome N. Inhibin forms in serum from postmenopausal women with ovarian cancer. Clin Endocrinol 1999; 50: 381–6.
  • Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organ systems. Genes Dev 1994; 8: 133–46.
  • Vihko KK, Piquette G, Hsueh AJW. Intraovarian signalling mechanisms and control. In: Grave GD, Gordon BC Jr (eds) Sexual Precocity: Etiology Diagnosis and Treatment. Raven Press, 1993: 253–61.
  • Bläuer M, Wichmann L, Punnonen R, Tuohimaa P. Measurement of activin B in human saliva and localization of activin subunits in rat salivary glands. Biochem Biophys Res Commun 1996; 222: 230–5.
  • Yamashita K, Yamato M, Shikone T, Minami S, Imai M, Nishimori K et al. Production of inhibin A and inhibin B in human ovarian sex cord tumors. Am J Obstet Gynecol 1997; 177: 1450–7.
  • Petraglia F, Luisi S, Pautier P, Sabourin JC, Rey R, Lhomme C et al. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J Clin Endocrinol Metab 1998; 83: 1029–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.